Your browser doesn't support javascript.
loading
Mouse models of human multiple myeloma subgroups.
Winkler, Wiebke; Farré Díaz, Carlota; Blanc, Eric; Napieczynska, Hanna; Langner, Patrick; Werner, Marvin; Walter, Barbara; Wollert-Wulf, Brigitte; Yasuda, Tomoharu; Heuser, Arnd; Beule, Dieter; Mathas, Stephan; Anagnostopoulos, Ioannis; Rosenwald, Andreas; Rajewsky, Klaus; Janz, Martin.
Afiliação
  • Winkler W; Immune Regulation and Cancer, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Farré Díaz C; Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Blanc E; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
  • Napieczynska H; Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
  • Langner P; Immune Regulation and Cancer, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Werner M; Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Walter B; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
  • Wollert-Wulf B; Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
  • Yasuda T; Core Unit Bioinformatics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin 10117, Germany.
  • Heuser A; Animal Phenotyping, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Beule D; Animal Phenotyping, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Mathas S; Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Anagnostopoulos I; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
  • Rosenwald A; Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
  • Rajewsky K; Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
  • Janz M; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin 13125, Germany.
Proc Natl Acad Sci U S A ; 120(10): e2219439120, 2023 03 07.
Article em En | MEDLINE | ID: mdl-36853944
Multiple myeloma (MM), a tumor of germinal center (GC)-experienced plasma cells, comprises distinct genetic subgroups, such as the t(11;14)/CCND1 and the t(4;14)/MMSET subtype. We have generated genetically defined, subgroup-specific MM models by the GC B cell-specific coactivation of mouse Ccnd1 or MMSET with a constitutively active Ikk2 mutant, mimicking the secondary NF-κB activation frequently seen in human MM. Ccnd1/Ikk2ca and MMSET/Ikk2ca mice developed a pronounced, clonally restricted plasma cell outgrowth with age, accompanied by serum M spikes, bone marrow insufficiency, and bone lesions. The transgenic plasma cells could be propagated in vivo and showed distinct transcriptional profiles, resembling their human MM counterparts. Thus, we show that targeting the expression of genes involved in MM subgroup-specific chromosomal translocations into mouse GC B cells translates into distinct MM-like diseases that recapitulate key features of the human tumors, opening the way to a better understanding of the pathogenesis and therapeutic vulnerabilities of different MM subgroups.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha